Goldentree Asset Management LP's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed May 29, 2024
- Accession no.
- 0001493152-24-021795
- Filed
- May 29, 2024, 4:33 PM ET
- Trade date
- May 24, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $8.25M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldentree Asset Management LPCIK 0001278951 | 10% Owner |
| Tananbaum Steven A.CIK 0001435626 | 10% Owner |
| GoldenTree Asset Management LLCCIK 0001435627 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2024 | Ordinary Shares | PPurchaseAcquired | +165,000 | $50.00 | +$8,250,000 | 3,039,035 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.